Theranexus Logo

Theranexus

A biopharma developing drugs for rare neurological diseases by targeting non-neuronal cells.

ALTHX | PA

Overview

Corporate Details

ISIN(s):
FR0013286259
LEI:
969500BFCV6IC7MFQP20
Country:
France
Address:
60 AVENUE ROCKEFELLER, 69008 LYON
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Theranexus is an innovative, clinical-stage biopharmaceutical company that emerged from the French Alternative Energies and Atomic Energy Commission (CEA). The company develops drug candidates for the treatment of rare neurological and central nervous system (CNS) diseases. It leverages a unique platform for the identification and characterization of advanced therapy drug candidates, focusing on the key role of non-neuronal cells (glial cells) to enhance therapeutic efficacy. The company's pipeline includes a drug candidate in clinical development for Batten disease.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-29 18:30
Regulatory News Service
Theranexus devient THX Pharma : une évolution stratégique vers la commercialisa…
French 211.7 KB
2025-09-29 18:30
Regulatory News Service
Theranexus Becomes THX Pharma: A Strategic Evolution Toward the Commercializati…
English 209.9 KB
2025-05-13 18:00
Regulatory News Service
THERANEXUS AND BEYOND BATTEN DISEASE FOUNDATION ANNOUNCE STRONG POSITIVE REAL-W…
English 391.8 KB
2025-05-13 18:00
Business and Financial Review
THERANEXUS ET LA FONDATION BEYOND BATTEN DISEASE ANNONCENT DES DONNÉES EN VIE R…
French 352.9 KB
2025-04-29 19:05
Registration Form
URD 2024
French 10.6 MB
2025-04-29 19:00
Earnings Release
THERANEXUS PUBLISHES ITS 2024 FULL-YEAR RESULTS, PRESENTS ITS PROGRESS REPORT A…
English 336.5 KB
2025-04-29 19:00
Earnings Release
THERANEXUS PUBLIE SES RÉSULTATS ANNUELS 2024, FAIT LE POINT SUR SES ACTIVITÉS E…
French 297.3 KB
2025-03-06 18:00
Regulatory News Service
MODIFICATION DU CONTRAT DE LIQUIDITÉ CONFIÉ À PORTZAMPARC
French 272.5 KB
2025-01-23 18:15
Report Publication Announcement
THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2025
English 262.8 KB
2025-01-23 18:00
Report Publication Announcement
THERANEXUS PUBLIE SON AGENDA FINANCIER POUR L'EXERCICE 2025
French 254.5 KB
2025-01-16 18:00
Declaration of Voting Results & Voting Rights Announcements
Information mensuelle relative au nombre total de droits de vote et d'actions c…
French 168.8 KB
2025-01-09 18:00
Report Publication Announcement
THERANEXUS ANNOUNCES THE PUBLICATION OF ITS LETTER TO SHAREHOLDERS
English 179.9 KB
2025-01-09 18:00
Report Publication Announcement
THERANEXUS ANNONCE LA PUBLICATION DE SA LETTRE AUX ACTIONNAIRES
French 181.7 KB
2024-12-17 18:15
Capital/Financing Update
THERANEXUS PRESENTS AN UPDATE OF ITS CASH POSITION AND FINANCING HORIZON
English 212.3 KB
2024-12-17 18:15
Capital/Financing Update
THERANEXUS FAIT UN POINT SUR SA POSITION DE TRÉSORERIE ET SON HORIZON DE FINANC…
French 230.9 KB

Automate Your Workflow. Get a real-time feed of all Theranexus filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Theranexus via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
HANATOUR SERVICE INC. Logo
South Korea's top travel firm offering package tours and custom trips for B2C & B2B clients.
South Korea 039130
Hanmi Science Co.,Ltd Logo
A holding company managing R&D-focused pharmaceutical, API, and medical device firms.
South Korea 008930
Heidelberg Pharma AG Logo
Develops cancer therapies using its proprietary ATAC Antibody-Drug Conjugate technology.
Germany HPHA
HighCo Logo
Data marketing firm offering digital solutions for brands & retailers to influence shopper behavior.
France HCO
H.I.S. Co., Ltd. Logo
A major Japanese travel agency providing global tour packages, lodging, and transport.
Japan 9603
Hit Co., Ltd. Logo
Specialized OOH advertising firm providing digital & static billboards in high-visibility areas.
Japan 378A
HLB Therapeutics Co.,Ltd. Logo
Develops innovative drugs for rare eye diseases and brain tumors, with vaccine logistics.
South Korea 115450
HONYAKU Center Inc. Logo
Provides industrial translation and interpreting for patent, legal, and corporate clients.
Japan 2483
A holding company for advanced materials, AI/data solutions, mobility, and global logistics.
South Korea 487570
Human Metabolome Technologies, Inc. Logo
A leader in metabolomics, providing CE-MS analysis to support R&D in biotech, pharma, and food.
Japan 6090

Talk to a Data Expert

Have a question? We'll get back to you promptly.